Last $1.75 USD
Change Today -0.0184 / -1.04%
Volume 23.1K
PIP On Other Exchanges
Symbol
Exchange
NYSE Amex
As of 11:29 AM 10/31/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mitchel B. Sayare Ph.D.

Chairman, Chairman of Governance & Nominating Committee and Member of Compensation Committee, PharmAthene, Inc.
AgeTotal Calculated CompensationThis person is connected to 21 board members in 2 different organizations across 4 different industries.

See Board Relationships
66$68,114

Background*

Dr. Mitchel B. Sayare, also known as Mitch, Ph.D. served as the Chief Executive Officer of ImmunoGen Inc. (a biotechnology company) from 1986 to January 1, 2009 and as its President from 1994 to July 29, 2008. From 1986 to 1992, Dr. Sayare served as the President of ImmunoGen Inc. From 1982 to 1985, Dr. Sayare served as a Vice President of Development at Xenogen Inc. Dr. Sayare has been the Chairman of PharmAthene, Inc. since July 15, 2011. Dr. Sayare served as the Chairman ...

Read Full Background

Corporate Headquarters*

One Park Place
Annapolis, Maryland 21401

United States

Phone: 410-269-2600
Fax: 410-269-2601

Board Members Memberships*

Former Director
Director
1986-2011
Former Director
1994-2008
Former Director, Chairman of Audit Committee and Member of Nominating Committee
2010-Present
Chairman, Chairman of Governance & Nominating Committee and Member of Compensation Committee

Education*

PhD
Temple University School Of Medicine
Bachelor's Degree
Ursinus College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$45,500
Total Calculated Compensation$68,114
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PIP:US $1.75 USD -0.0184

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Robert L. Parkinson Jr.Chairman, Chief Executive Officer and President
Baxter International Inc.
$1.5M
David Aviezer Ph.D., M.B.A.Chief Executive Officer, President, Executive Director and Chief Executive Officer of Protalix Ltd
Protalix BioTherapeutics, Inc.
$577.7K
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director and Member of Strategic Operations Committee
Emergent BioSolutions, Inc.
$1.0M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHARMATHENE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.